本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

SPYRE THERAPEUTICS INC

13.54
-0.0300-0.22%
成交量:21.55萬
成交額:288.25萬
市值:8.16億
市盈率:-4.26
高:13.80
開:13.22
低:13.06
收:13.57
資料載入中...
2025/03/07

重要事件披露

Form 8-K - Current report
2025/03/05

SEC問詢函

Form CORRESP - Correspondence
2025/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/02/27

重要事件披露

Form 8-K - Current report
2025/02/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/01/13

重要事件披露

Form 8-K - Current report
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/18

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

重要事件披露

Form 8-K - Current report